F.D.A. Clears New Cancer-Fighting Drug From Roche

.

F.D.A. Clears New Cancer-Fighting Drug From Roche

A new drug from the drug company Roche has been given the nod by the US Food and Drug Administration (FDA) to improve the treatment of patients suffering from a kind of cancer of the blood and bone marrow.

Roche is calling the new medicine Gazyva which is meant to fight chronic lymphocytic leukemia along with added treatment with chemotherapy. It is meant for those patients who have never before been treated for the same.

Gazyva provides relief in this cancer by destroying cancer cells and enabling the natural immune system of the body to fight against them.

The FDA gave its approval to Gazyva after proof that the drug along with chemotherapy was a better treatment to chemotherapy alone in slowing the progress of the cancer cells.

It was also seen that cancer patients who got treatment from Gazyva combined with chemotherapy had a higher survival rate with 23 months before death, relapse or spreading of the cancer cells.

Earlier treatments treated only with chemotherapy only got 11.1 months.

The new drug Gazyva will be sold by Roche s Genentech unit.


Latest News

Sea World Advertisement Says Killer Whales Live as Long in Captivity as in the W
Republican Senator, Ted Cruz to Compete for President’s Post; But Could his Birt
Ruth Porat to be Google’s New CFO
Fresh Competition Force Netflix, Hulu and Amazon to Look for New Technologies an
Cash-strapped Americans turn to Tax Refund Advances
Drone Manufacturers Have an Eye on North Dakota, Testing Ground for Unmanned Air
Tiffany’s Sales Decline due to a Strong Dollar
Bank of New York Mellon will settle Charges of Defrauding Customers for $714
Return Policy for Target’s Owned and Exclusive Brands Extended to One Year
Starbucks “Race Together” Idea Initiated by CEO Gets a Mixed Reaction
Brent Callinicos Uber’s CFO Steps Down to Spend More Time with Family
Even with the Perfect Design, Driverless Cars May Face Rare Circumstances that m